Judge Rules Pfizer's Lyrica Patents Are Valid
The patents for Pfizer Inc.'s blockbuster nerve pain drug Lyrica are valid, meaning Teva Pharmaceuticals Industries Ltd., Mylan Pharmaceuticals Inc. and others can't sell their planned generic versions, a Delaware federal...To view the full article, register now.
Already a subscriber? Click here to view full article